These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23225443)
1. Phase I study of combination chemotherapy consisting of paclitaxel, cisplatin, and S-1 in patients with unresectable gastric cancer (KOGC-02). Takahashi T; Saikawa Y; Fukuda K; Funakoshi S; Kawakubo H; Takeuchi H; Takaishi H; Kitagawa Y Anticancer Res; 2012 Dec; 32(12):5401-6. PubMed ID: 23225443 [TBL] [Abstract][Full Text] [Related]
2. A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer. Kimura Y; Yano H; Imamura H; Fujitani K; Imano M; Tokunaga Y; Matsuoka M; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H Jpn J Clin Oncol; 2013 Feb; 43(2):125-31. PubMed ID: 23225911 [TBL] [Abstract][Full Text] [Related]
3. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer. Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579 [TBL] [Abstract][Full Text] [Related]
4. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer. Ueda Y; Yamagishi H; Ichikawa D; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Takenaka A; Yamashita T; Kurioka H; Nishiyama M; Morita S; Nakamura K; Sakamoto J Oncology; 2005; 69(3):261-8. PubMed ID: 16138002 [TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer. Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784 [TBL] [Abstract][Full Text] [Related]
6. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method. Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983 [TBL] [Abstract][Full Text] [Related]
7. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T; Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763 [TBL] [Abstract][Full Text] [Related]
8. A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. Iwase H; Shimada M; Tsuzuki T; Ina K; Sugihara M; Haruta J; Shinoda M; Kumada T; Goto H Oncology; 2011; 80(1-2):76-83. PubMed ID: 21659786 [TBL] [Abstract][Full Text] [Related]
9. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558 [TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer. Kim JY; Do YR; Park KU; Kim JG; Chae YS; Kim MK; Lee KH; Ryoo HM; Bae SH; Baek JH; Song HS Cancer Chemother Pharmacol; 2011 Mar; 67(3):527-32. PubMed ID: 20461377 [TBL] [Abstract][Full Text] [Related]
11. A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Koizumi W; Nakayama N; Tanabe S; Sasaki T; Higuchi K; Nishimura K; Takagi S; Azuma M; Ae T; Ishido K; Nakatani K; Naruke A; Katada C Cancer Chemother Pharmacol; 2012 Feb; 69(2):407-13. PubMed ID: 21796483 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Sato Y; Takayama T; Sagawa T; Takahashi Y; Ohnuma H; Okubo S; Shintani N; Tanaka S; Kida M; Sato Y; Ohta H; Miyanishi K; Sato T; Takimoto R; Kobune M; Yamaguchi K; Hirata K; Niitsu Y; Kato J Cancer Chemother Pharmacol; 2010 Sep; 66(4):721-8. PubMed ID: 20041328 [TBL] [Abstract][Full Text] [Related]
13. A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer. Jiang H; Qian J; Zhao P; Zhang X; Zheng Y; Mao C; Zheng Y; Chen L; Wang Y; Mou H; Fang W; Teng L; Xu N Cancer Chemother Pharmacol; 2015 Jul; 76(1):197-203. PubMed ID: 26013324 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer. Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394 [TBL] [Abstract][Full Text] [Related]
15. Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. Hironaka S; Yamazaki K; Taku K; Yokota T; Shitara K; Kojima T; Ueda S; Machida N; Muro K; Boku N Jpn J Clin Oncol; 2010 Nov; 40(11):1014-20. PubMed ID: 20603245 [TBL] [Abstract][Full Text] [Related]
16. Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer. Fujitani K; Hasegawa H; Hirao M; Kurokawa Y; Tsujinaka T Anticancer Res; 2011 Sep; 31(9):3085-91. PubMed ID: 21868564 [TBL] [Abstract][Full Text] [Related]
17. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927 [TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer. Kawabata R; Fujiwara Y; Doki Y; Fujita J; Tsukahara Y; Yamasaki M; Miyata H; Takiguchi S; Monden M Oncology; 2007; 72(3-4):219-25. PubMed ID: 18176087 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256 [TBL] [Abstract][Full Text] [Related]
20. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer. Hokita S; Aikou T; Miyazono F; Ishigami S; Aridome K; Maenohara S; Saihara T; Suenaga K; Nomura H; Maeda S; Takatori H; Arima H; Uchikado Y; Natsugoe S; Takao S Cancer Chemother Pharmacol; 2006 Jun; 57(6):736-40. PubMed ID: 16163539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]